Investor Presentaiton slide image

Investor Presentaiton

Reinventing screening for lung cancer with a simpler and accessible option 150K Lung cancer deaths 86% INVESTOR 20 DAY 23 12M per year, leading cause of cancer-related death¹ Of eligible individuals are unscreened1 Unscreened individuals² GUARDANT 1. Jonas DE, Reuland DS, Reddy SM, et al. Screening for Lung Cancer With Low-Dose Computed Tomography: An Evidence Review for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. (Evidence Synthesis, No. 198.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK568573/ 2. American Lung Association: https://www.lung.org/media/press-releases/state-of-lung-cancer-2022#:~:text=The%202022%20%E2%80%9CState%20of%20Lung,rates%20as%20low%20as%201%25 130
View entire presentation